Safety, Harm, and Efficacy evaluation of IRRAflow vs External Ventricular Drainage for Patients with Intraventricular Hemorrhage: A Phase 2 Randomized Controlled Trial
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Brain and Spine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772529423000929 |
_version_ | 1797672026101514240 |
---|---|
author | Mette Haldup Niwar Mohamad Mads Rasmussen Stig Dyrskog Claus Simonsen Nikola Mikic Mads Grønhøj Joakim Wismann Frantz Rom Poulsen Mojtaba Nazari Naveed rehman Anders Korshøj |
author_facet | Mette Haldup Niwar Mohamad Mads Rasmussen Stig Dyrskog Claus Simonsen Nikola Mikic Mads Grønhøj Joakim Wismann Frantz Rom Poulsen Mojtaba Nazari Naveed rehman Anders Korshøj |
author_sort | Mette Haldup |
collection | DOAJ |
first_indexed | 2024-03-11T21:24:06Z |
format | Article |
id | doaj.art-9ea04e04aba9408fa3076caa97ce1129 |
institution | Directory Open Access Journal |
issn | 2772-5294 |
language | English |
last_indexed | 2024-03-11T21:24:06Z |
publishDate | 2023-01-01 |
publisher | Elsevier |
record_format | Article |
series | Brain and Spine |
spelling | doaj.art-9ea04e04aba9408fa3076caa97ce11292023-09-28T05:27:05ZengElsevierBrain and Spine2772-52942023-01-013101804Safety, Harm, and Efficacy evaluation of IRRAflow vs External Ventricular Drainage for Patients with Intraventricular Hemorrhage: A Phase 2 Randomized Controlled TrialMette Haldup0Niwar Mohamad1Mads Rasmussen2Stig Dyrskog3Claus Simonsen4Nikola Mikic5Mads Grønhøj6Joakim Wismann7Frantz Rom Poulsen8Mojtaba Nazari9 Naveed rehman10Anders Korshøj11Aarhus University Hospital, Aarhus, DenmarkAarhus University Hospital, Aarhus, DenmarkAarhus University Hospital, Aarhus, DenmarkAarhus University Hospital, Aarhus, DenmarkAarhus University Hospital, Aarhus, DenmarkAarhus University Hospital, Aarhus, DenmarkOdense University Hospital, Odense, DenmarkOdense University Hospital, Odense, DenmarkOdense University Hospital, Odense, DenmarkAarhus University, Aarhus, DenmarkAarhus University, Aarhus, DenmarkAarhus University Hospital, Aarhus, Denmarkhttp://www.sciencedirect.com/science/article/pii/S2772529423000929 |
spellingShingle | Mette Haldup Niwar Mohamad Mads Rasmussen Stig Dyrskog Claus Simonsen Nikola Mikic Mads Grønhøj Joakim Wismann Frantz Rom Poulsen Mojtaba Nazari Naveed rehman Anders Korshøj Safety, Harm, and Efficacy evaluation of IRRAflow vs External Ventricular Drainage for Patients with Intraventricular Hemorrhage: A Phase 2 Randomized Controlled Trial Brain and Spine |
title | Safety, Harm, and Efficacy evaluation of IRRAflow vs External Ventricular Drainage for Patients with Intraventricular Hemorrhage: A Phase 2 Randomized Controlled Trial |
title_full | Safety, Harm, and Efficacy evaluation of IRRAflow vs External Ventricular Drainage for Patients with Intraventricular Hemorrhage: A Phase 2 Randomized Controlled Trial |
title_fullStr | Safety, Harm, and Efficacy evaluation of IRRAflow vs External Ventricular Drainage for Patients with Intraventricular Hemorrhage: A Phase 2 Randomized Controlled Trial |
title_full_unstemmed | Safety, Harm, and Efficacy evaluation of IRRAflow vs External Ventricular Drainage for Patients with Intraventricular Hemorrhage: A Phase 2 Randomized Controlled Trial |
title_short | Safety, Harm, and Efficacy evaluation of IRRAflow vs External Ventricular Drainage for Patients with Intraventricular Hemorrhage: A Phase 2 Randomized Controlled Trial |
title_sort | safety harm and efficacy evaluation of irraflow vs external ventricular drainage for patients with intraventricular hemorrhage a phase 2 randomized controlled trial |
url | http://www.sciencedirect.com/science/article/pii/S2772529423000929 |
work_keys_str_mv | AT mettehaldup safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial AT niwarmohamad safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial AT madsrasmussen safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial AT stigdyrskog safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial AT claussimonsen safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial AT nikolamikic safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial AT madsgrønhøj safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial AT joakimwismann safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial AT frantzrompoulsen safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial AT mojtabanazari safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial AT naveedrehman safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial AT anderskorshøj safetyharmandefficacyevaluationofirraflowvsexternalventriculardrainageforpatientswithintraventricularhemorrhageaphase2randomizedcontrolledtrial |